IRLAB receives approval for phase Ib study with IRL757 in Parkinson’s disease: Gothenburg, Sweden Friday, December 26, 2025, 17:00 Hrs [IST] Sweden headquartered IRLAB, a compan ...
Morning Overview on MSN
Parkinson’s breakthrough rewrites what we know about dopamine
For decades, Parkinson’s disease has been framed as a simple story of dwindling dopamine, a slow erosion of the brain’s ...
The HealthWell Foundation funded Brukinsa (zanubrutinib) for Mike, enabling him to afford the treatment and maintain his ...
inews.co.uk on MSN
I reversed my Parkinson’s symptoms with daily doses of infrared light
A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back to driving and reduce his medication ...
Health professionals and community members recently gathered at the University of Arkansas for Medical Sciences (UAMS) Donald ...
We do know Parkinson's is caused by the loss of dopamine nerve cells in the part of the brain responsible for voluntary ...
A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...
For people living with Parkinson’s disease, there comes a point when medication doesn’t control the tremors the way it used ...
Enrollment will begin in January 2026Participants will be treated with buntanetap for 36 monthsThe study aims to enroll 500 ...
Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease ...
Anavex has requested from the EMA the re-examination, and will work closely with the EMA during this process. The re-examination procedure is led by a different rapporteur and co-rapporteur, who will ...
Despite negative equity, Amneal raised its operating cash flow guidance for FY25. Read why I agree with Wall St., which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback